The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
about
Chinese herbal medicines for treating osteoporosisEpidemiology and management of osteoporosis in the People's Republic of China: current perspectivesIn vivo screening for anti-osteoporotic fraction from extract of herbal formula Xianlinggubao in ovariectomized miceEffect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis.The Microbiome and Musculoskeletal Conditions of Aging: A Review of Evidence for Impact and Potential Therapeutics.Qianggu capsule for the treatment of primary osteoporosis: evidence from a Chinese patent medicine.Chinese herbal medicine for osteoporosis: a systematic review of randomized controlled trails.Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis.Icariin: does it have an osteoinductive potential for bone tissue engineering?Chinese herbal medicine for bone health.Total flavonoids from Rhizoma Drynariae (Gusuibu) for treating osteoporotic fractures: implication in clinical practice.Systematic review of traditional Chinese medicine for geriatrics.Artemisia capillaris Alleviates Bone Loss by Stimulating Osteoblast Mineralization and Suppressing Osteoclast Differentiation and Bone Resorption.The Combination of icariin and constrained dynamic loading stimulation attenuates bone loss in ovariectomy-induced osteoporotic mice.Biotransformation and metabolic profile of Xian-Ling-Gu-Bao capsule, a traditional Chinese medicine prescription, with rat intestinal microflora by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometSimultaneous Quantification of Multiple Representative Components in the Xian-Ling-Gu-Bao Capsule by Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Tandem Mass Spectrometry.Combination treatment with whole body vibration and a kidney-tonifying herbal Fufang prevent osteoporosis in ovariectomized rats.Herbal Fufang Xian Ling Gu Bao prevents corticosteroid-induced osteonecrosis of the femoral head-A first multicentre, randomised, double-blind, placebo-controlled clinical trial.A Traditional Herbal Formula Xianlinggubao for Pain Control and Function Improvement in Patients with Knee and Hand Osteoarthritis: A Multicenter, Randomized, Open-Label, Controlled Trial.Icariin: A promising osteoinductive compound for repairing bone defect and osteonecrosis.Icariin, but Not Genistein, Exerts Osteogenic and Anti-apoptotic Effects in Osteoblastic Cells by Selective Activation of Non-genomic ERα Signaling.
P2860
Q24198040-F845063C-8C9A-4013-AC19-A4B58240724CQ27005978-DAE39D66-D514-4339-916F-3BBC520FF086Q28543533-3FAC4664-4178-4F7C-8D0F-05F10A78A5F2Q33635025-C2A4B556-BE50-4627-A6A6-C12C8B1AD9C3Q35871201-CB2A0249-DDD1-417F-95A0-47E1F4246EFBQ36279297-6316ECE0-6A22-4555-BA0F-0A9C1097BAFFQ36610564-0C58B581-5C3A-4629-B6A4-00B8CE41DE59Q36883244-F22FF1A6-0C77-4797-A2AC-B73CD7F578F0Q38119188-0F16B416-D501-4250-8CD9-7F5C927D07ACQ38223141-F95767E2-039E-4CF4-B382-27CC2B045905Q38659759-FFEBD68D-1283-41FE-A687-20D7E380CBE7Q38858504-A828E2F7-D7A3-4804-8171-60F72BBE224FQ46276293-1EB3F46C-B7EC-4FD8-ADE5-DEE50D0C7567Q47421375-98871B87-DB93-4295-8CF3-5244028B037BQ48145011-40F315C2-3013-47A9-8FC1-0521057B72DDQ50606049-1EC6B7D9-40ED-45D3-8B94-0E3DF284B120Q51052449-8C0327E5-6409-4190-B50E-45C768457ACCQ52584269-4DF4FC10-01B4-482F-BF9A-DF70437FF5EDQ52606114-B5AD22D3-DCD4-447D-9F9D-9F1571D8AC92Q53262188-1182CA5E-BAEB-4D46-8043-ED13E3252200Q54977083-6D06B7E8-8F04-4E0C-BF3D-40A5CD5AA7B6
P2860
The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The first multicenter and rand ...... f postmenopausal osteoporosis.
@en
The first multicenter and rand ...... f postmenopausal osteoporosis.
@nl
type
label
The first multicenter and rand ...... f postmenopausal osteoporosis.
@en
The first multicenter and rand ...... f postmenopausal osteoporosis.
@nl
prefLabel
The first multicenter and rand ...... f postmenopausal osteoporosis.
@en
The first multicenter and rand ...... f postmenopausal osteoporosis.
@nl
P2093
P2860
P1476
The first multicenter and rand ...... f postmenopausal osteoporosis.
@en
P2093
H K Genant
P2860
P2888
P304
P356
10.1007/S00198-011-1577-2
P407
P577
2011-04-20T00:00:00Z